Project: New class of HIV inhibitors to overcome resistance to current drugs and improvement of a mouse model
| Acronym | ResistAIDS (Reference Number: 10239) |
| Duration | 01/04/2016 - 01/04/2019 |
| Project Topic | Highly active antiretroviral therapy is very effective at controlling HIV replication and associated mortality and morbidity. However the emergence and spread of viruses resistant to the drugs currently used is a growing public health threat. We want to develop a new class of anti-HIV drug that is fully active on all viruses resistant to current therapeutics, and will deliver a drug fully validated in phases I and IIa Proof of Concept clinical trials, and an improved mouse model of HIV infection |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 4 |